

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gamma-aminobutyric acid transport (GO:0015812) | 4.95647733 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 4.47545431 |
| 3 | activated T cell proliferation (GO:0050798) | 4.29329486 |
| 4 | behavioral response to nicotine (GO:0035095) | 3.88882906 |
| 5 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.86000568 |
| 6 | proline transport (GO:0015824) | 3.83925967 |
| 7 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.80303994 |
| 8 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.80303994 |
| 9 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.80303994 |
| 10 | negative regulation of B cell mediated immunity (GO:0002713) | 3.74711464 |
| 11 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.74711464 |
| 12 | positive T cell selection (GO:0043368) | 3.68013819 |
| 13 | protein K11-linked deubiquitination (GO:0035871) | 3.48358409 |
| 14 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.41413794 |
| 15 | positive regulation of granulocyte differentiation (GO:0030854) | 3.32365179 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.30863725 |
| 17 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.28860224 |
| 18 | negative T cell selection (GO:0043383) | 3.28670998 |
| 19 | histone H3-K4 trimethylation (GO:0080182) | 3.24510346 |
| 20 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.22360483 |
| 21 | DNA double-strand break processing (GO:0000729) | 3.21904420 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.21400551 |
| 23 | snRNA transcription (GO:0009301) | 3.15627809 |
| 24 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.15286528 |
| 25 | neural tube formation (GO:0001841) | 3.14712302 |
| 26 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.09386109 |
| 27 | negative regulation of granulocyte differentiation (GO:0030853) | 3.01467010 |
| 28 | regulation of granulocyte differentiation (GO:0030852) | 2.99115806 |
| 29 | negative thymic T cell selection (GO:0045060) | 2.97126980 |
| 30 | dopamine transport (GO:0015872) | 2.96099974 |
| 31 | mRNA splice site selection (GO:0006376) | 2.93787430 |
| 32 | somite development (GO:0061053) | 2.91152802 |
| 33 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.89917969 |
| 34 | response to pheromone (GO:0019236) | 2.88825360 |
| 35 | establishment of mitochondrion localization (GO:0051654) | 2.88023232 |
| 36 | transmission of nerve impulse (GO:0019226) | 2.87946723 |
| 37 | alpha-beta T cell differentiation (GO:0046632) | 2.85800259 |
| 38 | indolalkylamine metabolic process (GO:0006586) | 2.85611757 |
| 39 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.82928475 |
| 40 | Peyers patch development (GO:0048541) | 2.82928475 |
| 41 | interferon-gamma production (GO:0032609) | 2.81290258 |
| 42 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.80733122 |
| 43 | detection of light stimulus involved in visual perception (GO:0050908) | 2.80733122 |
| 44 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.79959567 |
| 45 | tolerance induction (GO:0002507) | 2.79655825 |
| 46 | olfactory bulb development (GO:0021772) | 2.75912406 |
| 47 | T cell selection (GO:0045058) | 2.74127943 |
| 48 | negative regulation of organelle assembly (GO:1902116) | 2.73276819 |
| 49 | positive regulation by host of viral transcription (GO:0043923) | 2.73189365 |
| 50 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.71411166 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.67163040 |
| 52 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.66572003 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61973378 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58331917 |
| 55 | histone H2A acetylation (GO:0043968) | 2.57571940 |
| 56 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.57049424 |
| 57 | positive regulation of protein deacetylation (GO:0090312) | 2.57037112 |
| 58 | neuronal action potential (GO:0019228) | 2.56421978 |
| 59 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.56018106 |
| 60 | mitochondrion transport along microtubule (GO:0047497) | 2.56018106 |
| 61 | regulation of memory T cell differentiation (GO:0043380) | 2.55958700 |
| 62 | dentate gyrus development (GO:0021542) | 2.54936801 |
| 63 | I-kappaB phosphorylation (GO:0007252) | 2.54612289 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.52519646 |
| 65 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.51370168 |
| 66 | mast cell degranulation (GO:0043303) | 2.51178178 |
| 67 | mast cell activation involved in immune response (GO:0002279) | 2.51178178 |
| 68 | fucose catabolic process (GO:0019317) | 2.50540444 |
| 69 | L-fucose metabolic process (GO:0042354) | 2.50540444 |
| 70 | L-fucose catabolic process (GO:0042355) | 2.50540444 |
| 71 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.49699364 |
| 72 | regulation of B cell differentiation (GO:0045577) | 2.46962549 |
| 73 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46336857 |
| 74 | nucleobase catabolic process (GO:0046113) | 2.45526361 |
| 75 | regulation of gamma-delta T cell activation (GO:0046643) | 2.44178234 |
| 76 | positive thymic T cell selection (GO:0045059) | 2.43598356 |
| 77 | mast cell activation (GO:0045576) | 2.43272354 |
| 78 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.41821794 |
| 79 | atrial cardiac muscle cell action potential (GO:0086014) | 2.41493008 |
| 80 | actin nucleation (GO:0045010) | 2.40534329 |
| 81 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.39233928 |
| 82 | response to interleukin-15 (GO:0070672) | 2.38730775 |
| 83 | alpha-beta T cell activation (GO:0046631) | 2.38174520 |
| 84 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.38098244 |
| 85 | regulation of Rab GTPase activity (GO:0032313) | 2.37766655 |
| 86 | positive regulation of Rab GTPase activity (GO:0032851) | 2.37766655 |
| 87 | negative regulation of neurotransmitter transport (GO:0051589) | 2.37038561 |
| 88 | histone H3-K4 methylation (GO:0051568) | 2.36393654 |
| 89 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.36323923 |
| 90 | histone H3-K9 modification (GO:0061647) | 2.34621034 |
| 91 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.34613056 |
| 92 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.34613056 |
| 93 | interkinetic nuclear migration (GO:0022027) | 2.34591249 |
| 94 | regulation of protein deacetylation (GO:0090311) | 2.34499103 |
| 95 | catecholamine transport (GO:0051937) | 2.34387661 |
| 96 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.32696440 |
| 97 | leukocyte aggregation (GO:0070486) | 2.30244011 |
| 98 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.29446830 |
| 99 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.29446830 |
| 100 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.29208035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.72463483 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.29849820 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.27777363 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.61002380 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.47165732 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.39212026 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.37318282 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.33767359 |
| 9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18896540 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05605684 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04085239 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00097312 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99393850 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98510001 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.91115405 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83073801 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73688454 |
| 18 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73202259 |
| 19 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71330308 |
| 20 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.71330308 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69178319 |
| 22 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.68565832 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.68417373 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66160596 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.62653432 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49433188 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47093655 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44339071 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41863620 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38846468 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33828786 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33398691 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29680805 |
| 34 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28610141 |
| 35 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.27218659 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26392636 |
| 37 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24648471 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24176585 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24117897 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23918706 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22674306 |
| 42 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22516011 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19756351 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.18780570 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17937581 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17841313 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17108728 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16916517 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.16899040 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16395852 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15943062 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14319151 |
| 53 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13234153 |
| 54 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12994341 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11515335 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.11079032 |
| 57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09934433 |
| 58 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09712015 |
| 59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09369245 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08407137 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.08364052 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08060761 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07984582 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06534514 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06534514 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05786387 |
| 67 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05662710 |
| 68 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.05221267 |
| 69 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03703433 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03674674 |
| 71 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02590568 |
| 72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01196793 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01191059 |
| 74 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.00231887 |
| 75 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00058485 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99530448 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98663638 |
| 78 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.98627609 |
| 79 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97558615 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97337325 |
| 81 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97239689 |
| 82 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96022466 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95706655 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95026489 |
| 85 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.94780419 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92982460 |
| 87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92199547 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91141120 |
| 89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90610556 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90407712 |
| 91 | MAF_26560356_Chip-Seq_TH1_Human | 0.90161910 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89386966 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89192677 |
| 94 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.87755003 |
| 95 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86891872 |
| 96 | EWS_26573619_Chip-Seq_HEK293_Human | 0.86200167 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85556678 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84466268 |
| 99 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84439561 |
| 100 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84216105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 3.25734960 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.06841012 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.01059268 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 2.98514120 |
| 5 | MP0000015_abnormal_ear_pigmentation | 2.49215622 |
| 6 | MP0003880_abnormal_central_pattern | 2.44838543 |
| 7 | MP0002102_abnormal_ear_morphology | 2.37364859 |
| 8 | MP0001986_abnormal_taste_sensitivity | 2.29509492 |
| 9 | MP0003787_abnormal_imprinting | 2.26502080 |
| 10 | MP0004381_abnormal_hair_follicle | 2.23785593 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.14036450 |
| 12 | MP0002638_abnormal_pupillary_reflex | 1.91517072 |
| 13 | MP0001968_abnormal_touch/_nociception | 1.88753474 |
| 14 | MP0008057_abnormal_DNA_replication | 1.85673053 |
| 15 | MP0004142_abnormal_muscle_tone | 1.83857137 |
| 16 | MP0005671_abnormal_response_to | 1.81111279 |
| 17 | MP0001800_abnormal_humoral_immune | 1.80703307 |
| 18 | MP0009046_muscle_twitch | 1.77846979 |
| 19 | MP0003878_abnormal_ear_physiology | 1.69413329 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 1.69413329 |
| 21 | MP0002009_preneoplasia | 1.68551421 |
| 22 | MP0008877_abnormal_DNA_methylation | 1.63404003 |
| 23 | MP0001188_hyperpigmentation | 1.62254624 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.60910846 |
| 25 | MP0000778_abnormal_nervous_system | 1.57074781 |
| 26 | MP0002928_abnormal_bile_duct | 1.52224437 |
| 27 | MP0003436_decreased_susceptibility_to | 1.50982738 |
| 28 | MP0002095_abnormal_skin_pigmentation | 1.50828912 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.49192793 |
| 30 | MP0003646_muscle_fatigue | 1.47394936 |
| 31 | MP0000371_diluted_coat_color | 1.41608171 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.41286050 |
| 33 | MP0002723_abnormal_immune_serum | 1.40291080 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.39066423 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.37780709 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.36050311 |
| 37 | MP0005387_immune_system_phenotype | 1.35901019 |
| 38 | MP0001790_abnormal_immune_system | 1.35901019 |
| 39 | MP0000685_abnormal_immune_system | 1.35589780 |
| 40 | MP0002405_respiratory_system_inflammati | 1.35343585 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.35043821 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.34431588 |
| 43 | MP0001819_abnormal_immune_cell | 1.33857559 |
| 44 | MP0004130_abnormal_muscle_cell | 1.31548308 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.29951199 |
| 46 | MP0004924_abnormal_behavior | 1.29951199 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.29372518 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.29064176 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.27770407 |
| 50 | MP0009745_abnormal_behavioral_response | 1.27201076 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.24077239 |
| 52 | MP0006276_abnormal_autonomic_nervous | 1.16252513 |
| 53 | MP0002398_abnormal_bone_marrow | 1.15768212 |
| 54 | MP0005025_abnormal_response_to | 1.15394570 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.14825085 |
| 56 | MP0000427_abnormal_hair_cycle | 1.13068649 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.12161192 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.11837947 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.11768852 |
| 60 | MP0000716_abnormal_immune_system | 1.11205087 |
| 61 | MP0008995_early_reproductive_senescence | 1.06534228 |
| 62 | MP0002272_abnormal_nervous_system | 1.06425230 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.06037898 |
| 64 | MP0002736_abnormal_nociception_after | 1.05541120 |
| 65 | MP0004133_heterotaxia | 1.04631964 |
| 66 | MP0002572_abnormal_emotion/affect_behav | 1.04152158 |
| 67 | MP0003724_increased_susceptibility_to | 1.02558077 |
| 68 | MP0009764_decreased_sensitivity_to | 1.00294644 |
| 69 | MP0009785_altered_susceptibility_to | 0.99893832 |
| 70 | MP0004742_abnormal_vestibular_system | 0.96929719 |
| 71 | MP0002064_seizures | 0.96691175 |
| 72 | MP0004885_abnormal_endolymph | 0.94807675 |
| 73 | MP0004859_abnormal_synaptic_plasticity | 0.94327666 |
| 74 | MP0003121_genomic_imprinting | 0.91256605 |
| 75 | MP0005499_abnormal_olfactory_system | 0.90545420 |
| 76 | MP0005394_taste/olfaction_phenotype | 0.90545420 |
| 77 | MP0001485_abnormal_pinna_reflex | 0.90404077 |
| 78 | MP0003122_maternal_imprinting | 0.90288418 |
| 79 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89409306 |
| 80 | MP0002419_abnormal_innate_immunity | 0.88690590 |
| 81 | MP0002229_neurodegeneration | 0.87951165 |
| 82 | MP0002722_abnormal_immune_system | 0.87372913 |
| 83 | MP0002933_joint_inflammation | 0.87184733 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.86678777 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.84742797 |
| 86 | MP0001905_abnormal_dopamine_level | 0.84045364 |
| 87 | MP0004147_increased_porphyrin_level | 0.83761000 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 0.82633474 |
| 89 | MP0000955_abnormal_spinal_cord | 0.82229187 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.80722659 |
| 91 | MP0001324_abnormal_eye_pigmentation | 0.79794418 |
| 92 | MP0002882_abnormal_neuron_morphology | 0.79075950 |
| 93 | MP0006082_CNS_inflammation | 0.77217695 |
| 94 | MP0008058_abnormal_DNA_repair | 0.76690377 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.76267275 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.76012519 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.74354879 |
| 98 | MP0005535_abnormal_body_temperature | 0.74182687 |
| 99 | MP0003303_peritoneal_inflammation | 0.73948162 |
| 100 | MP0002429_abnormal_blood_cell | 0.73802810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperventilation (HP:0002883) | 5.09439094 |
| 2 | Congenital stationary night blindness (HP:0007642) | 3.98974211 |
| 3 | Pancreatic fibrosis (HP:0100732) | 3.72648587 |
| 4 | Febrile seizures (HP:0002373) | 3.65797579 |
| 5 | Genetic anticipation (HP:0003743) | 3.58721031 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 3.27963565 |
| 7 | Tented upper lip vermilion (HP:0010804) | 3.20794100 |
| 8 | Pancreatic cysts (HP:0001737) | 3.14939082 |
| 9 | Atonic seizures (HP:0010819) | 3.12757461 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07416345 |
| 11 | Stomatitis (HP:0010280) | 3.06139755 |
| 12 | Absent speech (HP:0001344) | 3.00880211 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 2.98424570 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.91178420 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 2.87055087 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 2.79278203 |
| 17 | Decreased central vision (HP:0007663) | 2.74886197 |
| 18 | Broad-based gait (HP:0002136) | 2.74118559 |
| 19 | Amyotrophic lateral sclerosis (HP:0007354) | 2.66527922 |
| 20 | Stomach cancer (HP:0012126) | 2.65919691 |
| 21 | Thyroiditis (HP:0100646) | 2.65255952 |
| 22 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.62776694 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.60936494 |
| 24 | Ocular albinism (HP:0001107) | 2.58470375 |
| 25 | Drooling (HP:0002307) | 2.55091337 |
| 26 | Excessive salivation (HP:0003781) | 2.54388167 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46333747 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46333747 |
| 29 | True hermaphroditism (HP:0010459) | 2.44755270 |
| 30 | Diastasis recti (HP:0001540) | 2.41316205 |
| 31 | Combined immunodeficiency (HP:0005387) | 2.29180087 |
| 32 | Clumsiness (HP:0002312) | 2.26293933 |
| 33 | Epileptic encephalopathy (HP:0200134) | 2.25907027 |
| 34 | Hypoplastic iliac wings (HP:0002866) | 2.25905853 |
| 35 | Hypothermia (HP:0002045) | 2.25295865 |
| 36 | Protruding tongue (HP:0010808) | 2.25000170 |
| 37 | Thyroid-stimulating hormone excess (HP:0002925) | 2.23429083 |
| 38 | Encephalitis (HP:0002383) | 2.21839319 |
| 39 | Abnormality of B cell number (HP:0010975) | 2.19372228 |
| 40 | Type II lissencephaly (HP:0007260) | 2.19067082 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.18584677 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.18584677 |
| 43 | Iris hypopigmentation (HP:0007730) | 2.17514903 |
| 44 | Cystic liver disease (HP:0006706) | 2.15578600 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.15099940 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.13726021 |
| 47 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.12896437 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.09207715 |
| 49 | Alveolar cell carcinoma (HP:0006519) | 2.06965236 |
| 50 | Lissencephaly (HP:0001339) | 2.06394587 |
| 51 | Abnormality of the fingertips (HP:0001211) | 2.06358284 |
| 52 | Nephronophthisis (HP:0000090) | 2.06053230 |
| 53 | Pachygyria (HP:0001302) | 2.04481661 |
| 54 | Progressive microcephaly (HP:0000253) | 2.02740911 |
| 55 | Dyskinesia (HP:0100660) | 1.97476766 |
| 56 | Abnormality of the renal medulla (HP:0100957) | 1.97321294 |
| 57 | IgG deficiency (HP:0004315) | 1.96691675 |
| 58 | Abnormality of the renal cortex (HP:0011035) | 1.95114682 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93581937 |
| 60 | Prolonged QT interval (HP:0001657) | 1.93347284 |
| 61 | Obstructive sleep apnea (HP:0002870) | 1.92491272 |
| 62 | Dialeptic seizures (HP:0011146) | 1.91335753 |
| 63 | Leukocytosis (HP:0001974) | 1.90649963 |
| 64 | Polydipsia (HP:0001959) | 1.90551174 |
| 65 | Abnormal drinking behavior (HP:0030082) | 1.90551174 |
| 66 | Spastic gait (HP:0002064) | 1.89416330 |
| 67 | Gait imbalance (HP:0002141) | 1.89173571 |
| 68 | Abnormality of lateral ventricle (HP:0030047) | 1.88456340 |
| 69 | Stereotypic behavior (HP:0000733) | 1.88289159 |
| 70 | Widely spaced teeth (HP:0000687) | 1.87020657 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 1.84651146 |
| 72 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.82511824 |
| 73 | T lymphocytopenia (HP:0005403) | 1.82285983 |
| 74 | B lymphocytopenia (HP:0010976) | 1.80164846 |
| 75 | Bile duct proliferation (HP:0001408) | 1.79649812 |
| 76 | Abnormal biliary tract physiology (HP:0012439) | 1.79649812 |
| 77 | Shawl scrotum (HP:0000049) | 1.75760190 |
| 78 | Abnormality of T cells (HP:0002843) | 1.75262306 |
| 79 | Myositis (HP:0100614) | 1.75222368 |
| 80 | Prominent nose (HP:0000448) | 1.75130240 |
| 81 | Recurrent skin infections (HP:0001581) | 1.74204386 |
| 82 | Anencephaly (HP:0002323) | 1.74138510 |
| 83 | Intellectual disability, severe (HP:0010864) | 1.73556857 |
| 84 | Congenital hepatic fibrosis (HP:0002612) | 1.73203130 |
| 85 | Aqueductal stenosis (HP:0002410) | 1.72972659 |
| 86 | Ectopic kidney (HP:0000086) | 1.72912026 |
| 87 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.72193667 |
| 88 | Patellar aplasia (HP:0006443) | 1.70803551 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 1.69279034 |
| 90 | Poor eye contact (HP:0000817) | 1.69211053 |
| 91 | Chronic hepatic failure (HP:0100626) | 1.67969932 |
| 92 | Oligodactyly (hands) (HP:0001180) | 1.67765194 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67637424 |
| 94 | Absence seizures (HP:0002121) | 1.67064029 |
| 95 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.66874854 |
| 96 | Increased IgM level (HP:0003496) | 1.66159673 |
| 97 | Pendular nystagmus (HP:0012043) | 1.66134449 |
| 98 | Sleep apnea (HP:0010535) | 1.65476255 |
| 99 | Cerebellar dysplasia (HP:0007033) | 1.64701021 |
| 100 | Deep palmar crease (HP:0006191) | 1.64496725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK13 | 3.39364901 |
| 2 | FRK | 3.27029492 |
| 3 | CASK | 2.83929894 |
| 4 | IKBKE | 2.40605398 |
| 5 | SIK2 | 2.34979267 |
| 6 | TNK2 | 2.11676007 |
| 7 | MARK1 | 2.04730145 |
| 8 | TXK | 1.88721032 |
| 9 | SIK3 | 1.84684715 |
| 10 | NUAK1 | 1.79917045 |
| 11 | TAOK3 | 1.76494670 |
| 12 | SGK2 | 1.59694195 |
| 13 | CAMKK2 | 1.57557136 |
| 14 | DYRK1B | 1.55195277 |
| 15 | MAP4K1 | 1.51183562 |
| 16 | MARK3 | 1.45524129 |
| 17 | UHMK1 | 1.43732402 |
| 18 | PINK1 | 1.41932682 |
| 19 | AKT3 | 1.36576151 |
| 20 | WNK3 | 1.32154233 |
| 21 | MARK2 | 1.32033287 |
| 22 | CAMK1G | 1.27727848 |
| 23 | CAMK1D | 1.25597711 |
| 24 | STK38 | 1.24838177 |
| 25 | TRIM28 | 1.23365670 |
| 26 | GRK6 | 1.20687840 |
| 27 | CAMK4 | 1.18269658 |
| 28 | PRKCQ | 1.16815813 |
| 29 | MAP3K10 | 1.16745973 |
| 30 | NTRK2 | 1.13985289 |
| 31 | BTK | 1.11862712 |
| 32 | CAMKK1 | 1.11700447 |
| 33 | MAP3K6 | 1.10443687 |
| 34 | MAP3K4 | 1.09106926 |
| 35 | DAPK2 | 1.08896444 |
| 36 | ZAP70 | 1.08395162 |
| 37 | SGK494 | 1.08302828 |
| 38 | SGK223 | 1.08302828 |
| 39 | ITK | 1.07075628 |
| 40 | BMPR1B | 1.05865782 |
| 41 | ADRBK2 | 1.05321198 |
| 42 | KIT | 1.01868506 |
| 43 | DYRK2 | 0.99151604 |
| 44 | ERN1 | 0.98896004 |
| 45 | DYRK1A | 0.97810878 |
| 46 | SYK | 0.96350869 |
| 47 | FES | 0.95137866 |
| 48 | INSRR | 0.93315623 |
| 49 | HIPK2 | 0.90342389 |
| 50 | IKBKB | 0.90338535 |
| 51 | TRIB3 | 0.89170018 |
| 52 | CAMK1 | 0.88341495 |
| 53 | LCK | 0.86164057 |
| 54 | GRK1 | 0.82457455 |
| 55 | PKN1 | 0.81540522 |
| 56 | SGK3 | 0.81481379 |
| 57 | TEC | 0.80554490 |
| 58 | CDK19 | 0.80508975 |
| 59 | BRD4 | 0.78456404 |
| 60 | ZAK | 0.75563119 |
| 61 | PRKD3 | 0.74208537 |
| 62 | PRKCZ | 0.72033603 |
| 63 | STK11 | 0.71795043 |
| 64 | MAP2K6 | 0.68989285 |
| 65 | LYN | 0.68966100 |
| 66 | SIK1 | 0.67983176 |
| 67 | RPS6KA6 | 0.67428549 |
| 68 | ACVR1B | 0.65617614 |
| 69 | MAPK7 | 0.65468284 |
| 70 | MAP3K7 | 0.64606226 |
| 71 | MAP2K4 | 0.63469992 |
| 72 | PDK1 | 0.63315802 |
| 73 | PAK3 | 0.63134665 |
| 74 | PRKAA1 | 0.61328742 |
| 75 | PRKCH | 0.60547544 |
| 76 | EPHA4 | 0.59702213 |
| 77 | MAPK8 | 0.59491990 |
| 78 | TYK2 | 0.57678233 |
| 79 | MAP3K14 | 0.57353587 |
| 80 | CHUK | 0.56946923 |
| 81 | PRKD2 | 0.56327363 |
| 82 | STK16 | 0.54449361 |
| 83 | PIK3CG | 0.53845832 |
| 84 | SGK1 | 0.53715274 |
| 85 | WNK1 | 0.53343221 |
| 86 | RPS6KA2 | 0.53211391 |
| 87 | PRKAA2 | 0.52232584 |
| 88 | HCK | 0.51395992 |
| 89 | RPS6KC1 | 0.49795893 |
| 90 | RPS6KL1 | 0.49795893 |
| 91 | MAP3K11 | 0.49635090 |
| 92 | CSNK1D | 0.46656590 |
| 93 | PIM1 | 0.46552033 |
| 94 | TAF1 | 0.46253513 |
| 95 | MAP2K7 | 0.46134447 |
| 96 | MAPK12 | 0.46026318 |
| 97 | MKNK2 | 0.45931198 |
| 98 | BCKDK | 0.45666252 |
| 99 | RPS6KA1 | 0.44962356 |
| 100 | MAP2K3 | 0.43874613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.87752378 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.59273494 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.15601626 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.97106233 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.96096833 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 1.87184015 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86653021 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 1.74190625 |
| 9 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.70173022 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65380239 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60688016 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58976185 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58940262 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57872494 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.51768580 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49668316 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38903649 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38378879 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.34921856 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.33765111 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.30674942 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29896447 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.29320366 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27071500 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24642895 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.24317678 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22133425 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17275923 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13901837 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11512251 |
| 31 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.08440021 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.07747041 |
| 33 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.05532022 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.04818537 |
| 35 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04456098 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02469414 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01386909 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.00708484 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99443815 |
| 40 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98104599 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98077671 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 0.96998324 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95225318 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93656207 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93274521 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93198977 |
| 47 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92042911 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.91919989 |
| 49 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91445280 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 0.90146036 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89394227 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89153444 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86938184 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84724963 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83907756 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.83818165 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83039415 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.81644775 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81136681 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.80949129 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79968549 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.76707011 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75726689 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74956540 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74919062 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74569304 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72638868 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72493936 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72295122 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72290991 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72284436 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71764897 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69602804 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67723051 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67379136 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67044223 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.66110499 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.65495656 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64961916 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.64592536 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64406922 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62965713 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62217334 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62057424 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61831401 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61268371 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60605468 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59463310 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.58905820 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58626199 |
| 91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58014889 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57786050 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55798977 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55300491 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.55258516 |
| 96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53102545 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52510169 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51755845 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51538733 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.50329399 |

